# Clemastine Treatment in Individuals With Williams Syndrome

> **NCT06087757** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Sheba Medical Center** · enrollment: 30 (estimated)

## Conditions studied

- Williams Syndrome

## Interventions

- **DRUG:** Open Label Clemastine with a blinded randomize withdrawal

## Key facts

- **NCT ID:** NCT06087757
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-04-01
- **Primary completion:** 2026-05
- **Final completion:** 2026-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06087757

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06087757, "Clemastine Treatment in Individuals With Williams Syndrome". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06087757. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*